Stabilization period [Design Issues]

posted by Vismayi – India, 2023-06-26 21:55 (1098 d 02:00 ago) – Posting: # 23614
Views: 4,827

Good morning to one and all,

This is regarding patient PK study, we have upcoming study.

Indication: Ovary cancer

In this study,we need to stabilize patients but for how many days neither it is mentioned in specific guidance nor product leaflet. So, what duration we should we consider for stabilization.

Beside,study product can be taken until patient tolerate as per leaflet.


If the disease pre-valence is less and this may lead to challenge in recruitment. So can we consider replicate design over conventional two-way.


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
212 visitors (0 registered, 212 guests [including 16 identified bots]).
Forum time: 23:56 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5